-
1
-
-
84859603846
-
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease position paper
-
De Caterina R., Husted S., Wallentin L., Andreotti F., Arnesen H., Bachmann F., et al. New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol 2012, 59:1413-1425.
-
(2012)
J Am Coll Cardiol
, vol.59
, pp. 1413-1425
-
-
De Caterina, R.1
Husted, S.2
Wallentin, L.3
Andreotti, F.4
Arnesen, H.5
Bachmann, F.6
-
2
-
-
84863814810
-
Novel anticoagulants for non-valvular atrial fibrillation
-
Xu B., Whitbourn R. Novel anticoagulants for non-valvular atrial fibrillation. Heart Lung Circ 2012, 21:463-467.
-
(2012)
Heart Lung Circ
, vol.21
, pp. 463-467
-
-
Xu, B.1
Whitbourn, R.2
-
3
-
-
84891830360
-
-
Australian Register of Therapeutic Goods Public Summary - PRADAXA dabigatran etexilate 150mg. Available at: [accessed 07.09.13].
-
Australian Register of Therapeutic Goods Public Summary - PRADAXA dabigatran etexilate 150mg. Available at: [accessed 07.09.13]. http://www.ebs.tga.gov.au/servlet/xmlmillr6%3Fdbid=ebs/PublicHTML/pdfStore.nsf%26docid=488D5196B9F531F5CA257BB80042315D%26agid=(PrintDetailsPublic)%26actionid=1.
-
-
-
-
4
-
-
84891837111
-
-
Australian Register of Therapeutic Goods Public Summary - XARELTO rivaroxaban 20mg. Available at: [accessed 07.09.13].
-
Australian Register of Therapeutic Goods Public Summary - XARELTO rivaroxaban 20mg. Available at: [accessed 07.09.13]. http://www.ebs.tga.gov.au/servlet/xmlmillr6%3Fdbid=ebs/PublicHTML/pdfStore.nsf%26docid=1A8B73A173BCCFA0CA257B9C007EDC63%26agid=(PrintDetailsPublic)%26actionid=1.
-
-
-
-
5
-
-
84891832539
-
-
Australian Register of Therapeutic Goods Public Summary - ELIQUIS. Available at: [accessed 07.09.13].
-
Australian Register of Therapeutic Goods Public Summary - ELIQUIS. Available at: [accessed 07.09.13]. http://www.ebs.tga.gov.au/servlet/xmlmillr6%3Fdbid=ebs/PublicHTML/pdfStore.nsf%26docid=944549A4FCA15D97CA257BA900423723%26agid=(PrintDetailsPublic)%26actionid=1.
-
-
-
-
6
-
-
84891831981
-
-
Pharmaceutical Benefits Scheme (PBS) - DABIGATRAN. Available at: [accessed 07.09.13].
-
Pharmaceutical Benefits Scheme (PBS) - DABIGATRAN. Available at: [accessed 07.09.13]. http://www.pbs.gov.au/medicine/item/2769R.
-
-
-
-
7
-
-
84891830819
-
-
Pharmaceutical Benefits Scheme (PBS) - RIVAROXABAN. Available at: [accessed 07.09.13].
-
Pharmaceutical Benefits Scheme (PBS) - RIVAROXABAN. Available at: [accessed 07.09.13]. http://www.pbs.gov.au/medicine/item/2268J.
-
-
-
-
8
-
-
84891826958
-
-
Pharmaceutical Benefits Scheme (PBS) - APIXABAN. Available at: [accessed 07.09.13].
-
Pharmaceutical Benefits Scheme (PBS) - APIXABAN. Available at: [accessed 07.09.13]. http://www.pbs.gov.au/medicine/item/2735Y.
-
-
-
-
9
-
-
84891832867
-
-
FDA approves Pradaxa to prevent stroke in people with atrial fibrillation. Available at: [accessed 07.09.13].
-
FDA approves Pradaxa to prevent stroke in people with atrial fibrillation. Available at: [accessed 07.09.13]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm230241.htm.
-
-
-
-
10
-
-
84891835456
-
-
FDA approves Xarelto to prevent stroke in people with common type of abnormal heart rhythm. Available at: [accessed 07.09.13].
-
FDA approves Xarelto to prevent stroke in people with common type of abnormal heart rhythm. Available at: [accessed 07.09.13]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm278646.htm.
-
-
-
-
11
-
-
84891832668
-
-
FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation. Available at: [accessed 07.09.13].
-
FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation. Available at: [accessed 07.09.13]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333634.htm.
-
-
-
-
12
-
-
84891833285
-
-
European Medicines Agency - Find medicine - Pradaxa. Available at: [accessed 07.09.13].
-
European Medicines Agency - Find medicine - Pradaxa. Available at: [accessed 07.09.13]. http://www.emea.europa.eu/ema/index.jsp%3Fcurl=pages/medicines/human/medicines/000829/human_med_000981.jsp%26mid=WC0b01ac058001d124.
-
-
-
-
13
-
-
84891832261
-
-
European Medicines Agency - Find medicine - Xarelto. Available at: [accessed 07.09.13].
-
European Medicines Agency - Find medicine - Xarelto. Available at: [accessed 07.09.13]. http://www.ema.europa.eu/ema/index.jsp%3Fcurl=pages/medicines/human/medicines/000944/human_med_001155.jsp%26mid=WC0b01ac058001d124.
-
-
-
-
14
-
-
84891829470
-
-
ELIQUIS®(apixaban) approved in Europe for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Available at: [accessed 07.09.13].
-
ELIQUIS®(apixaban) approved in Europe for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Available at: [accessed 07.09.13]. http://news.bms.com/press-release/financial-news/eliquisapixaban-approved-europe-prevention-stroke-and-systemic-embolism%26t=634890181706594412.
-
-
-
-
15
-
-
77957932391
-
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)
-
Ruff C.T., Giugliano R.P., Antman E.M., Crugnale S.E., Bocanegra T., Mercuri M., et al. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). Am Heart J 2010, 160:635-641.
-
(2010)
Am Heart J
, vol.160
, pp. 635-641
-
-
Ruff, C.T.1
Giugliano, R.P.2
Antman, E.M.3
Crugnale, S.E.4
Bocanegra, T.5
Mercuri, M.6
-
16
-
-
79960261824
-
Guidelines on oral anticoagulation with warfarin - fourth edition
-
Keeling D., Baglin T., Tait C., Watson H., Perry D., Baglin C., et al. Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol 2011, 154:311-324.
-
(2011)
Br J Haematol
, vol.154
, pp. 311-324
-
-
Keeling, D.1
Baglin, T.2
Tait, C.3
Watson, H.4
Perry, D.5
Baglin, C.6
-
17
-
-
0037179656
-
Warfarin, aspirin, or both after myocardial infarction
-
Hurlen M., Abdelnoor M., Smith P., Erikssen J., Amesen H. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2002, 347:969-974.
-
(2002)
N Engl J Med
, vol.347
, pp. 969-974
-
-
Hurlen, M.1
Abdelnoor, M.2
Smith, P.3
Erikssen, J.4
Amesen, H.5
-
18
-
-
33645229796
-
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients
-
Andreotti F., Testa L., Biondi-Zoccari G.G., Crea F. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients. Eur Heart J 2006, 27:519-526.
-
(2006)
Eur Heart J
, vol.27
, pp. 519-526
-
-
Andreotti, F.1
Testa, L.2
Biondi-Zoccari, G.G.3
Crea, F.4
-
19
-
-
71849117615
-
Dabigatran versus warfarin in the treatment of acute venous thromboembolism
-
Schulman S., Kearon C., Kakkar A.K., Mismetti P., Schellong S., Eriksson H., et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009, 361:2342-2352.
-
(2009)
N Engl J Med
, vol.361
, pp. 2342-2352
-
-
Schulman, S.1
Kearon, C.2
Kakkar, A.K.3
Mismetti, P.4
Schellong, S.5
Eriksson, H.6
-
20
-
-
84891826663
-
-
A randomized trial of dabigatran versus warfarin in the treatment of acute venous thromboembolism (RE-COVER II). American Society of Hematology 2011 Annual Meeting. December 12, San Diego, CA, USA. Abstract 2005
-
Schulman S, Kakkar AK, Schellong SM, Goldhaber SZ, Henry E, Mismetti P, et al. A randomized trial of dabigatran versus warfarin in the treatment of acute venous thromboembolism (RE-COVER II). American Society of Hematology 2011 Annual Meeting. December 12, San Diego, CA, USA. Abstract 2005; 2011.
-
(2011)
-
-
Schulman, S.1
Kakkar, A.K.2
Schellong, S.M.3
Goldhaber, S.Z.4
Henry, E.5
Mismetti, P.6
-
21
-
-
84874003257
-
Extended use of dabigatran, warfarin or placebo in venous thromboembolism
-
Schulman S., Kearon C., Kakkar A.K., Schellong S., Eriksson H., Baanstra D., et al. Extended use of dabigatran, warfarin or placebo in venous thromboembolism. N Engl J Med 2013, 368:709-718.
-
(2013)
N Engl J Med
, vol.368
, pp. 709-718
-
-
Schulman, S.1
Kearon, C.2
Kakkar, A.K.3
Schellong, S.4
Eriksson, H.5
Baanstra, D.6
-
22
-
-
78650619315
-
Oral rivaroxaban for symptomatic venous thromboembolism
-
Bauersachs R., Berkowitz S.D., Brenner B., Buller H.R., Decousus H., Gallus A.S., et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010, 363:2499-2520.
-
(2010)
N Engl J Med
, vol.363
, pp. 2499-2520
-
-
Bauersachs, R.1
Berkowitz, S.D.2
Brenner, B.3
Buller, H.R.4
Decousus, H.5
Gallus, A.S.6
-
23
-
-
84859385808
-
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
-
Buller H.R., Prints M.H., Lensin A.W., Decousus H., Jacobson B.F., Minar E., et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012, 366:1287-1297.
-
(2012)
N Engl J Med
, vol.366
, pp. 1287-1297
-
-
Buller, H.R.1
Prints, M.H.2
Lensin, A.W.3
Decousus, H.4
Jacobson, B.F.5
Minar, E.6
-
24
-
-
79961199378
-
Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-Extension study)
-
Romualdi E., Donadini M.P., Ageno W. Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-Extension study). Expert Rev Cardiovasc Ther 2011, 9:841-844.
-
(2011)
Expert Rev Cardiovasc Ther
, vol.9
, pp. 841-844
-
-
Romualdi, E.1
Donadini, M.P.2
Ageno, W.3
-
25
-
-
84880327613
-
Oral apixaban for the treatment of acute venous thromboembolism
-
[Epub ahead of print]
-
Agnelli G., Buller H.R., Cohen A., Curto M., Gallus A.S., Johnson M., et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013, [Epub ahead of print]. 10.1056/NEJMoa1302507.
-
(2013)
N Engl J Med
-
-
Agnelli, G.1
Buller, H.R.2
Cohen, A.3
Curto, M.4
Gallus, A.S.5
Johnson, M.6
-
26
-
-
84873596181
-
Apixaban for extended treatment of venous thromboembolism
-
Agnelli G., Buller H.R., Cohen A., Curto M., Gallus A.S., Johnson M., et al. Apixaban for extended treatment of venous thromboembolism. N Engl J Med 2013, 368:699-708.
-
(2013)
N Engl J Med
, vol.368
, pp. 699-708
-
-
Agnelli, G.1
Buller, H.R.2
Cohen, A.3
Curto, M.4
Gallus, A.S.5
Johnson, M.6
-
27
-
-
84885618705
-
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism
-
Buller H.R., Decousus H., Grosso M.A., Mercuri M., Middeldorp S., Prins M., et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 2013, 10.1056/NEJMoa1306638.
-
(2013)
N Engl J Med
-
-
Buller, H.R.1
Decousus, H.2
Grosso, M.A.3
Mercuri, M.4
Middeldorp, S.5
Prins, M.6
-
28
-
-
80052232522
-
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
-
Oldgren J., Budaj A., Granger C.B., Khder Y., Roberts J., Siegbahn A., et al. Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial. Eur Heart J 2011, 32:2781-2789.
-
(2011)
Eur Heart J
, vol.32
, pp. 2781-2789
-
-
Oldgren, J.1
Budaj, A.2
Granger, C.B.3
Khder, Y.4
Roberts, J.5
Siegbahn, A.6
-
29
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
Connolly S.J., Ezekowitz M.D., Yusuf S., Eikelboom J., Oldgren J., Parekh A., et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009, 361:1139-1151.
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
Eikelboom, J.4
Oldgren, J.5
Parekh, A.6
-
30
-
-
84857021520
-
Dabigatran association with higher risk of acute coronary events
-
Uchino K., Hernandez A.V. Dabigatran association with higher risk of acute coronary events. Arch Intern Med 2012, 172:397-402.
-
(2012)
Arch Intern Med
, vol.172
, pp. 397-402
-
-
Uchino, K.1
Hernandez, A.V.2
-
31
-
-
84862907587
-
Rivaroxaban in patients with a recent acute coronary syndrome
-
Mega J.L., Braunwald E., Wiviott S.D., Bassand J.P., Bhatt D.L., Bode C., et al. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 2012, 366:9-19.
-
(2012)
N Engl J Med
, vol.366
, pp. 9-19
-
-
Mega, J.L.1
Braunwald, E.2
Wiviott, S.D.3
Bassand, J.P.4
Bhatt, D.L.5
Bode, C.6
-
32
-
-
80052162121
-
Apixaban with antiplatelet therapy after acute coronary syndrome
-
Alexander J.H., Lopes R.D., James S., Kilaru R., He Y., Mohan P., et al. Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 2011, 365:699-708.
-
(2011)
N Engl J Med
, vol.365
, pp. 699-708
-
-
Alexander, J.H.1
Lopes, R.D.2
James, S.3
Kilaru, R.4
He, Y.5
Mohan, P.6
-
33
-
-
36148983750
-
Prasugrel versus clopidogrel in patients with acute coronary syndromes
-
Wiviott S.D., Braunwald E., McCabe C.H., Montalescot G., Ruzyllo W., Gottlieb S., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007, 357:2001-2015.
-
(2007)
N Engl J Med
, vol.357
, pp. 2001-2015
-
-
Wiviott, S.D.1
Braunwald, E.2
McCabe, C.H.3
Montalescot, G.4
Ruzyllo, W.5
Gottlieb, S.6
-
34
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
Wallentin L., Becker R.C., Budaj A., Cannon C.P., Emanuelsson H., Held C., et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009, 361:1045-1057.
-
(2009)
N Engl J Med
, vol.361
, pp. 1045-1057
-
-
Wallentin, L.1
Becker, R.C.2
Budaj, A.3
Cannon, C.P.4
Emanuelsson, H.5
Held, C.6
-
35
-
-
84866368808
-
ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update)
-
Jneid H., Anderson J.L., Wright R.S., Adams C.D., Bridges C.R., Casey D.E., et al. ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update). J Am Coll Cardiol 2012, 60:645-681.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 645-681
-
-
Jneid, H.1
Anderson, J.L.2
Wright, R.S.3
Adams, C.D.4
Bridges, C.R.5
Casey, D.E.6
-
36
-
-
84866732231
-
ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
-
Steg P.G., James S.K., Atar D., Badano L.P., Lundgvist C.B., Borger M.A., et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012, 33:2569-2619.
-
(2012)
Eur Heart J
, vol.33
, pp. 2569-2619
-
-
Steg, P.G.1
James, S.K.2
Atar, D.3
Badano, L.P.4
Lundgvist, C.B.5
Borger, M.A.6
-
37
-
-
84856158305
-
ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
-
Hamm C.W., Bassand J.P., Agewall S., Bax J., Boersma E., Bueno H., et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011, 32:2999-3054.
-
(2011)
Eur Heart J
, vol.32
, pp. 2999-3054
-
-
Hamm, C.W.1
Bassand, J.P.2
Agewall, S.3
Bax, J.4
Boersma, E.5
Bueno, H.6
-
38
-
-
77957699729
-
Guidelines for the management of atrial fibrillation
-
Camm A.J., Kirchhof P., Lip G.Y.H., Schotten U., Savelieva I., Ernst S., et al. Guidelines for the management of atrial fibrillation. Eur Heart J 2010, 31:2369-2429.
-
(2010)
Eur Heart J
, vol.31
, pp. 2369-2429
-
-
Camm, A.J.1
Kirchhof, P.2
Lip, G.Y.H.3
Schotten, U.4
Savelieva, I.5
Ernst, S.6
-
39
-
-
77956899158
-
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
-
Hansen M.L., Sorensen R., Clausen M.T., Fog-Petersen M.L., Raunso J., Gadsboll N., et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 2010, 170:1433-1441.
-
(2010)
Arch Intern Med
, vol.170
, pp. 1433-1441
-
-
Hansen, M.L.1
Sorensen, R.2
Clausen, M.T.3
Fog-Petersen, M.L.4
Raunso, J.5
Gadsboll, N.6
-
40
-
-
84875720372
-
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
-
Dedilde W.J.M., Oirbans T., Verheugt F.W.A., Kelder J.C., De Smet B.J.G.L., Herrman J.-P., et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 2013, 381:1107-1115.
-
(2013)
Lancet
, vol.381
, pp. 1107-1115
-
-
Dedilde, W.J.M.1
Oirbans, T.2
Verheugt, F.W.A.3
Kelder, J.C.4
De Smet, B.J.G.L.5
Herrman, J.-P.6
-
41
-
-
84855851690
-
Thrombosis on a mechanical aortic valve whilst anti-coagulated with dabigatran
-
Stewart R.A., Astell H., Young L., White H.D. Thrombosis on a mechanical aortic valve whilst anti-coagulated with dabigatran. Heart Lung Circ 2012, 21:53-55.
-
(2012)
Heart Lung Circ
, vol.21
, pp. 53-55
-
-
Stewart, R.A.1
Astell, H.2
Young, L.3
White, H.D.4
-
42
-
-
84867570927
-
Mechanical valve thrombosis with dabigatran
-
Price J., Hynes M., Labinaz M., Ruel M., Boodhwani M. Mechanical valve thrombosis with dabigatran. J Am Coll Cardiol 2012, 60:1710-1711.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 1710-1711
-
-
Price, J.1
Hynes, M.2
Labinaz, M.3
Ruel, M.4
Boodhwani, M.5
-
43
-
-
84865657840
-
Thrombosis of a mechanical heart valve despite dabigatran
-
Chu J.W., Chen V.H., Bunton R. Thrombosis of a mechanical heart valve despite dabigatran. Ann Intern Med 2012, 157:304.
-
(2012)
Ann Intern Med
, vol.157
, pp. 304
-
-
Chu, J.W.1
Chen, V.H.2
Bunton, R.3
-
44
-
-
84884512133
-
Dabigatran versus warfarin in patients with mechanical heart valves
-
Eikelboom J.W., Connolly S.J., Brueckmann M., Granger C.B., Kappetein A.P., Mack M.J., et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 2013, 10.1056/NEJMoa1300615.
-
(2013)
N Engl J Med
-
-
Eikelboom, J.W.1
Connolly, S.J.2
Brueckmann, M.3
Granger, C.B.4
Kappetein, A.P.5
Mack, M.J.6
-
45
-
-
84891834120
-
-
Boehringer Ingelheim discontinues Phase II trial in patients with artificial heart valves. Available at: [accessed 07.09.13].
-
Boehringer Ingelheim discontinues Phase II trial in patients with artificial heart valves. Available at: [accessed 07.09.13]. http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2012/11_december_2012dabigatranetexilate1.html.
-
-
-
|